361 related articles for article (PubMed ID: 12560899)
21. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
[TBL] [Abstract][Full Text] [Related]
22. Obesity does not increase complications after anatomic resection for non-small cell lung cancer.
Smith PW; Wang H; Gazoni LM; Shen KR; Daniel TM; Jones DR
Ann Thorac Surg; 2007 Oct; 84(4):1098-105; discussion 1105-6. PubMed ID: 17888954
[TBL] [Abstract][Full Text] [Related]
23. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
Ludwig C; Stoelben E; Olschewski M; Hasse J
Ann Thorac Surg; 2005 Mar; 79(3):968-73. PubMed ID: 15734415
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.
Cigolari S; Curcio C; Maiorino A; Sessa R; Cioffi A; Massimo M
Anticancer Res; 2003; 23(2C):1803-9. PubMed ID: 12820462
[TBL] [Abstract][Full Text] [Related]
25. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
Fischer S; Darling G; Pierre AF; Sun A; Leighl N; Waddell TK; Keshavjee S; de Perrot M
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1129-34. PubMed ID: 18407511
[TBL] [Abstract][Full Text] [Related]
26. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
27. Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer.
Subotic DR; Mandaric DV; Eminovic TM; Gajic MM; Mujovic NM; Atanasijadis ND; Dzeletovic PP; Andric LD; Bulajic BM; Dimitrijevic ID; Sobic DP
J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1292-9. PubMed ID: 17976465
[TBL] [Abstract][Full Text] [Related]
28. Bronchopleural fistula in the surgery of non-small cell lung cancer: incidence, risk factors, and management.
Sirbu H; Busch T; Aleksic I; Schreiner W; Oster O; Dalichau H
Ann Thorac Cardiovasc Surg; 2001 Dec; 7(6):330-6. PubMed ID: 11888471
[TBL] [Abstract][Full Text] [Related]
29. Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer.
Spaggiari L; D' Aiuto M; Veronesi G; Pelosi G; de Pas T; Catalano G; de Braud F
Ann Thorac Surg; 2005 Jan; 79(1):234-40. PubMed ID: 15620949
[TBL] [Abstract][Full Text] [Related]
30. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
31. Does chemotherapy increase morbidity and mortality after pneumonectomy?
Alan S; Jan S; Tomas H; Robert L; Jan S; Pavel P
J Surg Oncol; 2009 Jan; 99(1):38-41. PubMed ID: 18985632
[TBL] [Abstract][Full Text] [Related]
32. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
33. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience.
Takeda S; Maeda H; Koma M; Matsubara Y; Sawabata N; Inoue M; Tokunaga T; Ohta M
Eur J Cardiothorac Surg; 2006 Mar; 29(3):276-80. PubMed ID: 16434204
[TBL] [Abstract][Full Text] [Related]
34. Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.
Choi IS; Oh DY; Kwon JH; Kim SI; Park SR; Bak JY; Kim JH; Kim DW; Kim YT; Kim TY; You CK; Kim YW; Heo DS; Bang YJ; Sung SW; Park CI; Kim NK
Jpn J Clin Oncol; 2005 Jan; 35(1):6-12. PubMed ID: 15681597
[TBL] [Abstract][Full Text] [Related]
35. Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy.
Andrade RS; Kesler KA; Wilson JL; Brooks JA; Reichwage BD; Rieger KM; Einhorn LH; Brown JW
Ann Thorac Surg; 2004 Oct; 78(4):1224-8; discussion 1228-9. PubMed ID: 15464475
[TBL] [Abstract][Full Text] [Related]
36. The mortality from acute respiratory distress syndrome after pulmonary resection is reducing: a 10-year single institutional experience.
Tang SS; Redmond K; Griffiths M; Ladas G; Goldstraw P; Dusmet M
Eur J Cardiothorac Surg; 2008 Oct; 34(4):898-902. PubMed ID: 18768325
[TBL] [Abstract][Full Text] [Related]
37. [The effect of multimodality induction therapy for locally advanced non-small cell lung cancer].
Yamada T; Nakashima Y; Tanahashi M; Hikosaka Y; Yoshitomi H; Niwa H
Kyobu Geka; 2005 Oct; 58(11):969-75. PubMed ID: 16235845
[TBL] [Abstract][Full Text] [Related]
38. 15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer.
Shargall Y; de Perrot M; Keshavjee S; Darling G; Ginsberg R; Johnston M; Pierre A; Waddell TK
Lung Cancer; 2004 Sep; 45(3):357-63. PubMed ID: 15301876
[TBL] [Abstract][Full Text] [Related]
39. Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection.
Song SW; Lee HS; Kim MS; Lee JM; Kim JH; Nam BH; Zo JI
Ann Thorac Surg; 2006 Jun; 81(6):1974-81. PubMed ID: 16731116
[TBL] [Abstract][Full Text] [Related]
40. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
